Fresh analysis suggests that individuals who discontinue blockbuster slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise programs.
Research printed in a prominent health publication points out that while overweight people frequently drop a large proportion of their body weight while using the jabs, the weight returns at an estimated rate of nearly a kilo each month once they quit.
"Individuals using these drugs need to be aware of the danger of fast weight regain when the treatment concludes," stated expert Dr. Susan Jebb.
This pace of recovery suggests a reversion to pre-treatment mass within about one and a half years.
Analyzing Treatments
The analysis, which examined dozens of trials involving over 9,000 of patients, contrasted the results of GLP-1 agonists with other pills.
Scientists emphasize that people who lose weight through dieting typically experience a slower creep back—around 0.1 kg a month—after stopping.
The Reason for the Fast Regain
Doctors propose the way of the drugs is key to understanding the heightened weight return.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of the hormone concentrations far above than the body's typical production could lead to the body to produce less of its own natural GLP-1, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication leads to appetite is no longer kept in check, making binge eating a significant risk."
A Lifelong Condition?
Health authorities recommend the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes.
Professionals contend that, considering the likelihood of weight regain, the therapy might need to be long-term.
This perspective is supported by drug manufacturers, who state that the results "emphasize the persistent character of excess weight," similar to managing conditions like diabetes.
Patient Accounts
Users who have come off the jabs explain a sudden return of cravings.
"It felt as if a switch flipping and you become starving," described one woman.
This difficulty is exacerbated if users have not adopted sustainable dietary or behavioural changes during treatment.
Widespread Use
Survey data suggest that millions of people in the UK have used these injections in the last 12 months, with demand continuing to grow.
- Adoption is more common among women than men.
- The middle-aged age group shows the greatest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
Ultimately, experts caution that while these medications are powerful tools for weight loss, they are not a standalone fix and maintained weight loss relies on ongoing behavioural management.